Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carotino is a leading nutraceutical and functional food company specializing in the production of red palm oil and natural phytonutrient concentrates. As a member of the J.C. Chang Group, the company utilizes a patented, chemical-free physical refining process to extract high concentrations of alpha and beta-carotenes and tocotrienols (Vitamin E) from palm fruit. Their products serve the global food, pharmaceutical, and cosmetic industries as health-enhancing ingredients and dietary supplements. Carotino is actively involved in clinical research, supporting studies on the efficacy of tocotrienols in neuroprotection and cardiovascular health. The company maintains a vertically integrated supply chain, ensuring sustainability and traceability from plantation to finished product. Their manufacturing facilities are certified to international standards, including GMP and HACCP, to meet the rigorous requirements of the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carotino.